Track the Azitra, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2m. The latest transaction was reported on 18 June 2026 (C). Among the most active insiders: Salva Francisco D.. All data is free.
5
Insider Decl.
n/a
Thresholds
€107,214
4 ops.
Buy Volume
n/a
n/a
Sell Volume
49Σ signal
Buys €107,214n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,300 shares@ US$0.309.0% of flowCommon StockSEC:0001493152-24-006914:0
Canonical exit: 13 May 2024 (T+90)
5 of 5 declarations
About Azitra, Inc.
Azitra, Inc. is a company listed on the XNAS market, focused on developing bacteria-based therapies for treating skin diseases. The firm emphasizes innovation in the dermatological care sector.